Which of the following statements is true concerning the operation of a transcutaneous carbon dioxide electrode?
a. PtcCO2 readings are slightly lower than the PaCO2 value.
b. Electrodes should be calibrated when they are repositioned.
c. Heating the transcutaneous PCO2 (PtcCO2) to 43°C will adversely affect its operation.
d. Before its use, the electrode should be calibrated to 20% and 40% CO2.
ANS: B
Manufacturers typically suggest calibration of an electrode each time it is repositioned. PtcCO2 readings are slightly higher than the PaCO2 value because of the higher metabolic rate at the site of the electrode caused by heating the skin. The PtcCO2 electrode must be heated to 42° C to 44° C. The PtcCO2 electrodes are calibrated with a two-point calibration procedure by using 5% CO2 and 10% calibration gases.
You might also like to view...
Your patient is a 52-year-old male complaining of shortness of breath. He is sitting up, alert, and oriented and appears to be in moderate respiratory distress. He states that he "always gets a chest cold in the winter" and describes a three-week history of productive cough and increasing shortness of breath. Physical examination reveals coarse rhonchi to the upper lobes bilaterally, air movement
is decreased in the bases, and his skin is cool with peripheral cyanosis. You note that he is overweight and describes an 18-pack-a-year smoking history. Based on these clinical exam findings, the most clinically relevant finding you might also expect is: A) pursed-lipped breathing. B) JVD, ankle edema, and hepatic congestion. C) pulmonary edema and hypotension. D) barrel chest and increased anterior/posterior chest diameter.
In which phase of a clinical drug trial does the drug developer test the drug on between 1,000 and 3,000 volunteers who present with the condition the drug purports to treat, over a period of anywhere from 2 to 10 years?
A) Phase 2 B) Phase 4 C) Phase 3 D) Phase 1